Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 2009

View Archived Issues

Nihon Medi-Physics presents compounds useful for the diagnosis of Alzheimer's disease

Friedrich-Alexander-University claims 5-HT1A receptor agonists as anxiolytics

AR-67 shows high lactone stability and improved toxicity in phase I trial in refractory solid tumors

Novel oncolytic adenovirus Ad5/3-Cox2L-D24 shows clinical safety and promising antitumor activity

Snapshots: promising therapies for central nervous system tumors presented at ASCO

Pfizer describes prostaglandin EP2 antagonists for the treatment of endometriosis

Novel antibacterial agents in early development at AstraZeneca

Novel protein kinase inhibitors discovered by Schering-Plough for cancer treatment

BN-82451 reduces levodopa-induced dyskinesias in primate Parkinson's disease model

Positive results seen with fipamezole in proof-of-concept Parkinson's disease study

AEterna Zentaris reports preliminary results from phase II trial of perifosine in NSCLC

GSK forms joint venture with Shenzhen for influenza vaccines in China

EMEA approves DOR BioPharma's design of phase III clinical trial of orBec in GI GVHD

Peplin initiates phase III trials of PEP-005 in face and scalp actinic keratoses

InSite to initiate pilot study of ISV-502 in blepharitis to enable revision of phase III protocol

NOXXON initiates dosing of healthy volunteers in phase I clinical trial of NOX-E36

Ono initiates clinical testing in Japan of Relistor for opioid-induced constipation

TD-5108 shows similar effects on bowel function in healthy and constipated subjects

Novel potent and selective compounds developed by RaQualia for the treatment of GERD

ZK-EPO is active in metastatic melanoma but not recurrent metastatic breast cancer in phase II trial

Raptor and Roche sign collaboration agreement for therapeutic delivery across BBB

Roche selects rHuPH20 as fifth exclusive target under license agreement with Halozyme

Keryx reports results from phase II study of Zerenex for hyperphosphatemia in ESRD

Trius reports phase II clinical trial results of torezolid in cSSSI

ISTA announces phase II results for low-dose bromfenac in dry eye disease

Pacgen signs share purchase agreement with Xphase

Pharmasset initiates phase Ib multiple ascending dose trial for PSI-7851 in HCV

Renovo presents 12-month data for Juvista in varicose vein surgery

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 11, 2025.
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld Asia
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty
BioWorld
With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...